Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NT... AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.02 | 1.3986013986 | 1.43 | 1.465 | 1.3695 | 41700 | 1.42939904 | CS |
| 4 | 0.32 | 28.3185840708 | 1.13 | 1.465 | 1.085 | 137754 | 1.21911658 | CS |
| 12 | 0.06 | 4.31654676259 | 1.39 | 1.465 | 1.0499 | 133231 | 1.21754193 | CS |
| 26 | 0.39 | 36.7924528302 | 1.06 | 1.675 | 0.975 | 328078 | 1.22631951 | CS |
| 52 | -1.77 | -54.9689440994 | 3.22 | 3.88 | 0.87 | 374368 | 1.47979211 | CS |
| 156 | -15.4 | -91.3946587537 | 16.85 | 23.58 | 0.87 | 193107 | 4.31057364 | CS |
| 260 | -15.4 | -91.3946587537 | 16.85 | 23.58 | 0.87 | 193107 | 4.31057364 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
